FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3016265876> ?p ?o ?g. }

• W3016265876 abstract "EVIDENS is an ongoing, prospective, non-interventional study evaluating the effectiveness and safety of nivolumab in lung cancer patients in France (ClinicalTrials.gov NCT03382496).Adults with a pathologically confirmed diagnosis of lung cancer and initiating treatment with nivolumab were recruited from 146 sites in France. This analysis included only patients with non-small cell lung cancer (NSCLC) who received ≥1 nivolumab infusion, and evaluated patient characteristics at the time of nivolumab initiation and its effectiveness and safety after a median follow-up of 18 months.A total of 1,420 patients with NSCLC were included, most of whom had an Eastern Cooperative Oncology Group performance status (ECOG PS) of 0–1 (82.9%), non-squamous histology (69.2%) and stage IV disease (91.4%). Brain metastases were present in 19.9% of patients. Nivolumab was a second-line or ≥third-line regimen in 73.6% and 26.1% of patients, respectively. Almost all patients had prior chemotherapy (99.7%). Median overall survival was 11.2 months (95% confidence interval [CI]: 10.0–12.4). ECOG PS, smoking status, corticosteroids at baseline, epidermal growth factor receptor mutation status, presence of symptomatic brain metastases and treatment-related adverse events (TRAEs) were independent predictors of survival. Grade 3 and 4 TRAEs were reported in 105 (7.4%) and 12 (0.8%) patients, respectively; no treatment-related deaths were reported.Preliminary results of the EVIDENS study confirm the effectiveness and safety of nivolumab, mostly in pre-treated advanced NSCLC patients, with similar benefits to those observed in the phase III randomized clinical trials, despite a broader study population." @default.
• W3016265876 created "2020-04-17" @default.
• W3016265876 creator A5001860947 @default.
• W3016265876 creator A5002994604 @default.
• W3016265876 creator A5004346372 @default.
• W3016265876 creator A5004698755 @default.
• W3016265876 creator A5004829147 @default.
• W3016265876 creator A5006139634 @default.
• W3016265876 creator A5022875313 @default.
• W3016265876 creator A5028065894 @default.
• W3016265876 creator A5028953047 @default.
• W3016265876 creator A5035630320 @default.
• W3016265876 creator A5036018448 @default.
• W3016265876 creator A5036049078 @default.
• W3016265876 creator A5041314794 @default.
• W3016265876 creator A5043045128 @default.
• W3016265876 creator A5045519884 @default.
• W3016265876 creator A5049633907 @default.
• W3016265876 creator A5052417668 @default.
• W3016265876 creator A5071118692 @default.
• W3016265876 creator A5073425557 @default.
• W3016265876 creator A5074040711 @default.
• W3016265876 creator A5081717712 @default.
• W3016265876 creator A5083786421 @default.
• W3016265876 creator A5087253397 @default.
• W3016265876 creator A5087836238 @default.
• W3016265876 creator A5091592799 @default.
• W3016265876 date "2020-01-01" @default.
• W3016265876 modified "2023-10-16" @default.
• W3016265876 title "Effectiveness and safety of nivolumab in the treatment of lung cancer patients in France: preliminary results from the real-world EVIDENS study" @default.
• W3016265876 cites W1971211622 @default.
• W3016265876 cites W1972053944 @default.
• W3016265876 cites W1998340100 @default.
• W3016265876 cites W2104347254 @default.
• W3016265876 cites W2112117200 @default.
• W3016265876 cites W2132611552 @default.
• W3016265876 cites W2156353875 @default.
• W3016265876 cites W2162055363 @default.
• W3016265876 cites W2198093519 @default.
• W3016265876 cites W2559678440 @default.
• W3016265876 cites W2564670228 @default.
• W3016265876 cites W2567564314 @default.
• W3016265876 cites W2767214532 @default.
• W3016265876 cites W2767395872 @default.
• W3016265876 cites W2768743357 @default.
• W3016265876 cites W2800538231 @default.
• W3016265876 cites W2884761157 @default.
• W3016265876 cites W2885738414 @default.
• W3016265876 cites W2886464002 @default.
• W3016265876 cites W2897930258 @default.
• W3016265876 cites W2906601155 @default.
• W3016265876 cites W2908622615 @default.
• W3016265876 cites W2911188335 @default.
• W3016265876 cites W2917911017 @default.
• W3016265876 cites W2936171087 @default.
• W3016265876 cites W2939507240 @default.
• W3016265876 cites W2944824119 @default.
• W3016265876 cites W2967398918 @default.
• W3016265876 cites W2998298043 @default.
• W3016265876 cites W4210992155 @default.
• W3016265876 doi "https://doi.org/10.1080/2162402x.2020.1744898" @default.
• W3016265876 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7790497" @default.
• W3016265876 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33457089" @default.
• W3016265876 hasPublicationYear "2020" @default.
• W3016265876 type Work @default.
• W3016265876 sameAs 3016265876 @default.
• W3016265876 citedByCount "28" @default.
• W3016265876 countsByYear W30162658762020 @default.
• W3016265876 countsByYear W30162658762021 @default.
• W3016265876 countsByYear W30162658762022 @default.
• W3016265876 countsByYear W30162658762023 @default.
• W3016265876 crossrefType "journal-article" @default.
• W3016265876 hasAuthorship W3016265876A5001860947 @default.
• W3016265876 hasAuthorship W3016265876A5002994604 @default.
• W3016265876 hasAuthorship W3016265876A5004346372 @default.
• W3016265876 hasAuthorship W3016265876A5004698755 @default.
• W3016265876 hasAuthorship W3016265876A5004829147 @default.
• W3016265876 hasAuthorship W3016265876A5006139634 @default.
• W3016265876 hasAuthorship W3016265876A5022875313 @default.
• W3016265876 hasAuthorship W3016265876A5028065894 @default.
• W3016265876 hasAuthorship W3016265876A5028953047 @default.
• W3016265876 hasAuthorship W3016265876A5035630320 @default.
• W3016265876 hasAuthorship W3016265876A5036018448 @default.
• W3016265876 hasAuthorship W3016265876A5036049078 @default.
• W3016265876 hasAuthorship W3016265876A5041314794 @default.
• W3016265876 hasAuthorship W3016265876A5043045128 @default.
• W3016265876 hasAuthorship W3016265876A5045519884 @default.
• W3016265876 hasAuthorship W3016265876A5049633907 @default.
• W3016265876 hasAuthorship W3016265876A5052417668 @default.
• W3016265876 hasAuthorship W3016265876A5071118692 @default.
• W3016265876 hasAuthorship W3016265876A5073425557 @default.
• W3016265876 hasAuthorship W3016265876A5074040711 @default.
• W3016265876 hasAuthorship W3016265876A5081717712 @default.
• W3016265876 hasAuthorship W3016265876A5083786421 @default.
• W3016265876 hasAuthorship W3016265876A5087253397 @default.
• W3016265876 hasAuthorship W3016265876A5087836238 @default.
• W3016265876 hasAuthorship W3016265876A5091592799 @default.
• W3016265876 hasBestOaLocation W30162658761 @default.
• W3016265876 hasConcept C121608353 @default.
• W3016265876 hasConcept C126322002 @default.

• next